Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CAPR

Capricor Therapeutics (CAPR)

Capricor Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CAPR
DateTimeSourceHeadlineSymbolCompany
11/02/202501:00GlobeNewswire Inc.Capricor Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CAPRCapricor Therapeutics Inc
06/02/202509:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
07/01/202511:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
03/01/202506:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CAPRCapricor Therapeutics Inc
03/01/202501:15GlobeNewswire Inc.Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular DystrophyNASDAQ:CAPRCapricor Therapeutics Inc
17/12/202401:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
05/12/202412:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CAPRCapricor Therapeutics Inc
03/12/202408:15GlobeNewswire Inc.Capricor Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CAPRCapricor Therapeutics Inc
21/11/202401:00GlobeNewswire Inc.Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines AgencyNASDAQ:CAPRCapricor Therapeutics Inc
15/11/202408:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CAPRCapricor Therapeutics Inc
14/11/202408:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CAPRCapricor Therapeutics Inc
14/11/202408:01GlobeNewswire Inc.Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CAPRCapricor Therapeutics Inc
13/11/202403:46Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CAPRCapricor Therapeutics Inc
13/11/202401:00GlobeNewswire Inc.Capricor Therapeutics to Present Exosome Platform Updates at 2024 American Association of Extracellular Vesicles Annual MeetingNASDAQ:CAPRCapricor Therapeutics Inc
12/11/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CAPRCapricor Therapeutics Inc
06/11/202401:00GlobeNewswire Inc.Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13NASDAQ:CAPRCapricor Therapeutics Inc
25/10/202405:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CAPRCapricor Therapeutics Inc
23/10/202408:11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CAPRCapricor Therapeutics Inc
19/10/202407:01GlobeNewswire Inc.Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:CAPRCapricor Therapeutics Inc
18/10/202407:15Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CAPRCapricor Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CAPR